For the year ending 2025-12-31, MC had $96,186K increase in cash & cash equivalents over the period. $539,967K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 259,617 |
| Bad debt expense (benefit) | 739 |
| Depreciation and amortization | 11,879 |
| Equity-based compensation | 230,261 |
| Deferred tax provision (benefit) | 50,029 |
| Gain on partial sale of equity method investment | 19,092 |
| Other | 13,257 |
| Accounts receivable | 31,236 |
| Accrued and other receivables | 5,517 |
| Prepaid expenses and other assets | 8,866 |
| Deferred compensation | 13,536 |
| Compensation payable | 91,250 |
| Accounts payable, accrued expenses and other liabilities | 18,234 |
| Deferred revenue | 3,445 |
| Dividends received from equity method investment | 2,347 |
| Net cash provided by (used in) operating activities | 576,297 |
| Purchases of investments | 524,754 |
| Proceeds from sales of investments | 335,791 |
| Note payments (issued to) employees | 845 |
| Note payments received from employees | 250 |
| Proceeds from partial sale of equity method investment | 29,916 |
| Purchases of equipment and leasehold improvements | 36,330 |
| Net cash provided by (used in) investing activities | -195,972 |
| Payments for dividends and tax distributions | 208,703 |
| Payments for treasury stock purchases | 74,591 |
| Payments under tax receivable agreement | 314 |
| Other distributions | -288 |
| Net cash provided by (used in) financing activities | -283,896 |
| Effect of exchange rate fluctuations on cash, cash equivalents, and restricted cash | -243 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 96,186 |
| Cash, cash equivalents, and restricted cash, beginning of period | 413,179 |
| Cash, cash equivalents, and restricted cash, end of period | 509,365 |
Moelis & Co (MC)
Moelis & Co (MC)